51 results on '"Cystic fibrosis -- Care and treatment -- Health aspects"'
Search Results
2. BiomX to Share Findings from the BX004 Phase 1b|2a Trial in Cystic Fibrosis Patients with Persistent Lung Infections at ECCMID 2024
3. Device For Inducing Vibrations Of The Chest Wall To Ensure The Therapeutic Opening Of Airways, Support Of Bronchial Drainage. It Is Intended For Patients With Respiratory Illness With Impaired Mucociliary Clearance, For Post-traumatic Conditions, Copd, Cy
4. Supply Of A Medicinal Product For Medical Use - Siponimod For The Treatment Of Patients With Hemophilia, Cystic Fibrosis, Pituitary Dwarfism, Gaucher Disease, Malignant Neoplasms Of Lymphoid, Hematopoietic And Related Tissues, Multiple Sclerosis, Hemolyti
5. Gastrointestinal mucormycosis post lung transplantation
6. Researchers at University of Pittsburgh Release New Data on Mycobacteria (Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages In 20 Patients With Drug-resistant Mycobacterial Disease)
7. Aridis' treatment of lung infections in CF patients granted orphan designation
8. Reports from Technion-Israel Institute of Technology Highlight Recent Findings in Cystic Fibrosis (Compassionate Nitric Oxide Adjuvant Treatment of Persistent Mycobacterium Infection in Cystic Fibrosis Patients)
9. Ukraine : Orphan diseases: what free services can a patient receive under the Medical Guarantees Program, - NSZU
10. Mast Therapeutics Announces Clinical Study Of AIR001 For The Treatment Of Chronic Infection In Cystic Fibrosis Patients
11. Research highlights potential for CRISPR in fight against antibiotic resistance
12. University Medical Center, Tubingen Details Findings in Cystic Fibrosis (Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study)
13. New treatment kills off infection that can be deadly in cystic fibrosis
14. New treatment to kill infection deadly to cystic fibrosis patients
15. Investigating the antimicrobial efficacy of mesenchymal stromal cells as a novel potential therapy for Mycobacterium avium pulmonary infection
16. Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection in People Living with Cystic Fibrosis
17. New Cystic Fibrosis Data Have Been Reported by Researchers at Medical and Pharmaceutical University (Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis)
18. First physio to be a Cystic Fibrosis Trust fellow improves hospital infection control
19. Savara Provides Update on Case Reports of Inhaled Granulocyte-Macrophage Colony Stimulating Factor for the Treatment of Nontuberculous Mycobacteria Infection
20. Proteostasis Receives Endorsement from the Cystic Fibrosis Foundation's Therapeutic Development Network for the Study of the Company's Amplifier, PTI-428, in CF Subjects on Background Symdeko Therapy
21. Proteostasis Receives Endorsement from the Cystic Fibrosis Foundation's Therapeutic Development Network for the Study of the Company's Amplifier, PTI-428, in CF Subjects on Background Symdeko(TM) Therapy
22. Investigators at Case Western Reserve University Zero in on Liposomes (Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis)
23. Data on Lung Diseases and Conditions Reported by Researchers at University of Naples Federico II (Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa ...)
24. New Findings on Liposomes from C.S. Haworth and Co-Authors Summarized [Inhaled Liposomal Ciprofloxacin In Patients With Non-cystic Fibrosis Bronchiectasis and Chronic Lung Infection With Pseudomonas Aeruginosa (Orbit-3 and Orbit-4): Two Phase 3, ...]
25. AIT Therapeutics' Adjuvant Nitric Oxide Treatment Shown to be Safe and Effective in the Compassionate Use Setting in Cystic Fibrosis Patients with Non-tuberculous Mycobacteria (NTM) Infection
26. Mast Therapeutics Announces Clinical Study Of AIR001 For The Treatment Of Chronic Infection In Cystic Fibrosis Patients
27. FDA panel doesn't back inhaled ciprofloxacin for chronic lung infections
28. Horizon Pharma plc Announces Availability of QUINSAIR (levofloxacin inhalation solution) in Canada for the Treatment of Specific Lung Infections in Adults with Cystic Fibrosis
29. Horizon Pharma plc Announces Availability of QUINSAIR(TM) (levofloxacin inhalation solution) in Canada for the Treatment of Specific Lung Infections in Adults with Cystic Fibrosis
30. Cystic Fibrosis Breakthrough for Patients With Fungal Infections in Lungs
31. New Findings in the Area of Mycology Reported from C. Schwarz and Colleagues (Invasive Pulmonary Fungal Infections in Cystic Fibrosis)
32. Research paves the way for treatment strategies of multidrug-resistant chronic infections
33. Garlic can fight chronic infections
34. New Pseudomonas aeruginosa Study Findings Have Been Reported by B. Porsio and Co-Researchers (Nano into Micro Formulations of Tobramycin for the Treatment of Pseudomonas aeruginosa Infections in Cystic Fibrosis)
35. Reports from Johns Hopkins University Advance Knowledge in Cystic Fibrosis (Impaired Renal Function Should Not Be a Barrier to Transplantation in Patients With Cystic Fibrosis)
36. Arno Therapeutics' AR-13 Data Show Promise as Potential New Therapeutic Option for Cystic Fibrosis Patients With Serious Bacterial Infections
37. Investigators from University of Pittsburgh Target Cystic Fibrosis (Digging through the Obstruction: Insight into the Epithelial Cell Response to Respiratory Virus Infection in Patients with Cystic Fibrosis)
38. Researchers recruit seaweed in fight against infection
39. Insmed Announces First Patient Dosed in Pivotal European Phase 3 Clinical Study of ARIKACE[R] in Cystic Fibrosis Patients with Pseudomonas Lung Infections
40. New polymyxin for cystic fibrosis and chronic lung infections
41. Arikace demonstrates sustained benefit in multiple studies and over multiple cycles of treatment of pseudomonas lung infections in cystic fibrosis patients
42. ARIKACE(TM) Demonstrates Sustained Benefit in Multiple Studies and Over Multiple Cycles of Treatment of Pseudomonas Lung Infections in Cystic Fibrosis Patients
43. New Cystic Fibrosis Data Have Been Reported by Researchers at Department of Pediatrics (Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis)
44. KaloBios Initiates Phase 1/2 Trial of Humaneered(TM) Monoclonal Antibody KB001 for Treatment of Pseudomonas Infections in Cystic Fibrosis Patients
45. Study Data from University of Pennsylvania Update Understanding of Cystic Fibrosis (Lung transplantation in patients with cystic fibrosis: special focus to infection and comorbidities)
46. Studies from University of North Carolina Have Provided New Information about Cystic Fibrosis (Respiratory infections in patients with cystic fibrosis undergoing lung transplantation)
47. Combination therapy provides hope for cure of dangerous infections of cystic fibrosis patients
48. ARIKACE Demonstrates Sustained Benefit in Multiple Studies and Over Multiple Cycles of Treatment of Pseudomonas Lung Infections in Cystic Fibrosis Patients
49. Research from S. Esposito et al has provided new information about pandemics
50. Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.